After Hours Summary: AMAG +42% spikes on rumors of takeover deal; SELB -45% slides on Phase 2 COMPARE trial dataAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: N/A
Companies trading higher in after hours in reaction to news: AMAG +42% (in talks to be acquired by Covis Pharma, per Bloomberg), SBH +7% (to join the S&P SmallCap 600), SAIL +6.6% (to join the S&P MidCap 400), PRVB +5.9% (announced submission of clinical module for teplizumab BLA), FLR +4.4% (awarded $1.1 bln Navy contract), PLTR +3.5% (continued volatility following public debut), KDMN +2.8% (submitted NDA for belumosudil for the treatment of patients with cGVHD), AMC +3% (to reopen additional theaters in California and Michigan), FMCI +1.9% (stockholders approve extending date to complete business combination to October 30), IONS +1.2% (ION373 received orphan drug designation for the treatment of Alexander disease)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: N/A
Companies trading lower in after hours in reaction to news: ZSAN -53.7% (received discipline review letter for Qtrypta NDA), SELB -45.2% (announced top-line data from Phase 2 COMPARE trial), LOGC -23.9% (announced public offering of common stock), CLI -5.2% (suspends dividends for Q3 and Q4), MDT -0.9% (under investigation in ventilator antitrust probe, according to WSJ)